Understanding the structural insights of enzymatic conformations for adenylosuccinate lyase receptor in malarial parasite Plasmodium falciparum

References

• Danasekaran R, Mani G, Annadurai K, et al. Small bite, big threat: the burden of vector-borne diseases. Iran J Public Health. 2014;43:1014–1015.
   PubMed Web of Science ®Google Scholar
• Perez-Guaita D, Marzec KM, Hudson A, et al. Parasites under the spotlight: applications of vibrational spectroscopy to malaria research. Chem Rev. 2018;118:5330–5358.
   PubMed Web of Science ®Google Scholar
• Eastman RT, Fidock DA. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol. 2009;7:864–874.
   PubMed Web of Science ®Google Scholar
• Cui L, Mharakurwa S, Ndiaye D, et al. Antimalarial drug resistance: literature review and activities and findings of the ICEMR network. Am J Trop Med Hyg. 2015;93:57–68.
   PubMed Web of Science ®Google Scholar
• Nilsson SK, Childs LM, Buckee C, et al. Targeting human transmission biology for malaria elimination. PLoS Pathog. 2015;11:e1004871.
   PubMed Web of Science ®Google Scholar
• Aly AS, Vaughan AM, Kappe SH. Malaria parasite development in the mosquito and infection of the mammalian host. Annu Rev Microbiol. 2009;63:195–221.
   PubMed Web of Science ®Google Scholar
• Mideo N, Reece SE, Smith AL, et al. The Cinderella syndrome: why do malaria-infected cells burst at midnight? Trends Parasitol. 2013;29:10–16.
   PubMed Web of Science ®Google Scholar
• Schetters I. Why do malaria parasites sequester? Parasitol Today. 2000;16:132.
   PubMedGoogle Scholar
• Antinori S, Galimberti L, Milazzo L, et al. Biology of human malaria plasmodia including Plasmodium knowlesi. Mediterr J Hematol Infect Dis. 2012;4:e2012013.
   PubMedGoogle Scholar
• Ramasamy R. Zoonotic malaria – global overview and research and policy needs. Front Public Health. 2014;2:123
   PubMedGoogle Scholar
• Padmanaban G. Drug targets in malaria parasites. Adv Biochem Eng Biotechnol. 2003;84:123–141.
   PubMedGoogle Scholar
• Franco R, Canela EI. Computer simulation of purine metabolism. Eur J Biochem. 1984;144:305–315.
   PubMedGoogle Scholar
• Banerjee S, Agrawal MJ, Mishra D, et al. Structural and kinetic studies on adenylosuccinate lyase from Mycobacterium smegmatis and Mycobacterium tuberculosis provide new insights on the catalytic residues of the enzyme. FEBS J. 2014;281:1642–1658.
   PubMed Web of Science ®Google Scholar
• Ducati RG, Namanja-Magliano HA, Schramm VL. Transition-state inhibitors of purine salvage and other prospective enzyme targets in malaria. Future Med Chem. 2013;5:1341–1360.
   PubMed Web of Science ®Google Scholar
• Toth EA, Yeates TO. The structure of adenylosuccinate lyase, an enzyme with dual activity in the de novo purine biosynthetic pathway. Structure. 2000;8:163–174.
   PubMed Web of Science ®Google Scholar
• Finn RD, Tate J, Mistry J, et al. The Pfam protein families database. Nucleic Acids Res. 2008;36:D281–D288.
   PubMed Web of Science ®Google Scholar
• Selvaraj C, Singh P, Singh SK. Molecular modeling studies and comparative analysis on structurally similar HTLV and HIV protease using HIV-PR inhibitors. J Recept Signal Transduct Res. 2014;34:361–371.
   PubMed Web of Science ®Google Scholar
• Selvaraj C, Sivakamavalli J, Vaseeharan B, et al. Examine the characterization of biofilm formation and inhibition by targeting SrtA mechanism in Bacillus subtilis: a combined experimental and theoretical study. J Mol Model. 2014;20:2364.
   PubMed Web of Science ®Google Scholar
• Gyulkhandanyan A, Rezaie AR, Roumenina L, Lagarde N, et al. Analysis of protein missense alterations by combining sequence- and structure-based methods. Mol Genet Genomic Med. 2020;8:e1166.
   PubMed Web of Science ®Google Scholar
• Peninal S, Subramanian J, Elavarasi A, et al. Genetic identification of marine eels through DNA barcoding from Parangipettai coastal waters. Genom Data. 2017;11:81–84.
   PubMedGoogle Scholar
• Selvaraj C, Dinesh DC, Panwar U, et al. Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19. J Biomol Struct Dyn. 2020.
   Google Scholar
• Chinnasamy S, Selvaraj G, Selvaraj C, et al. Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2). Int J Biol Macromol. 2020;144:53–66.
   PubMed Web of Science ®Google Scholar
• Sayeed U, Wadhwa G, Khan MK, et al. An immuno-informatics driven epitope study from the molecular interaction of JEV non-structural (NS) proteins with ribophorin (RPN). Bioinformation. 2014;10:496–501.
   PubMedGoogle Scholar
• Kumar A, Pandey R, Yadav IS, et al. Structural and epitope analysis (T- and B-cell epitopes) of hepatitis C virus (HCV) glycoproteins: an in silico approach. J Clin Exp Hepatol. 2018;8:352–361.
   PubMed Web of Science ®Google Scholar
• Pontius J, Richelle J, Wodak SJ. Deviations from standard atomic volumes as a quality measure for protein crystal structures. J Mol Biol. 1996;264:121–136.
   PubMed Web of Science ®Google Scholar
• Pettersen EF, Goddard TD, Huang CC, Couch GS, et al. UCSF Chimera – a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605–1612.
   PubMed Web of Science ®Google Scholar
• Binkowski TA, Naghibzadeh S, Liang J. CASTp: computed atlas of surface topography of proteins. Nucleic Acids Res. 2003;31:3352–3355.
   PubMed Web of Science ®Google Scholar
• Selvaraj C, Singh P, Singh SK. Molecular insights on analogs of HIV PR inhibitors toward HTLV-1 PR through QM/MM interactions and molecular dynamics studies: comparative structure analysis of wild and mutant HTLV-1 PR. J Mol Recognit. 2014;27:696–706.
   PubMed Web of Science ®Google Scholar
• Godugu D, Rupula K, Sashidhar RB. Binding studies of andrographolide with human serum albumin: molecular docking, chromatographic and spectroscopic studies. Protein Pept Lett. 2018;25:330–338.
   PubMed Web of Science ®Google Scholar
• Farzaneh S, Zeinalzadeh E, Daraei B, et al. New ferrocene compounds as selective cyclooxygenase (COX-2) inhibitors: design, synthesis, cytotoxicity and enzyme-inhibitory activity. Anticancer Agents Med Chem. 2018;18:295–301.
   PubMed Web of Science ®Google Scholar
• Liu H, Li G, Zhang B, et al. Suppression of the NFκB signaling pathway in colon cancer cells by the natural compound riccardin D from dumortierahirsute. Mol Med Rep. 2018;17:5837–5843.
   PubMed Web of Science ®Google Scholar
• Sandeep G, Nagasree KP, Hanisha M, et al. AUDocker LE: a GUI for virtual screening with AUTODOCK Vina. BMC Res Notes. 2011;4:445.
   PubMedGoogle Scholar
• Selvaraj C, Sakkiah S, Tong W, et al. Molecular dynamics simulations and applications in computational toxicology and nanotoxicology. Food Chem Toxicol. 2018;112:495–506.
   PubMed Web of Science ®Google Scholar
• Vijayalakshmi P, Selvaraj C, Shafreen RM, et al. Ligand-based pharmacophore modelling and screening of DNA minor groove binders targeting Staphylococcus aureus. J Mol Recognit. 2014;27:429–437.
   PubMed Web of Science ®Google Scholar
• Beema Shafreen RM, Selvaraj C, Singh SK, et al. In silico and in vitro studies of cinnamaldehyde and their derivatives against LuxS in Streptococcus pyogenes: effects on biofilm and virulence genes. J Mol Recognit. 2014;27:106–116.
   PubMed Web of Science ®Google Scholar